These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2983805)

  • 1. Reversal of paralysis in nerve-muscle preparations isolated from animals with hereditary motor endplate disease.
    Harris JB; Pollard SL
    Br J Pharmacol; 1985 Jan; 84(1):6-8. PubMed ID: 2983805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitatory effects of 4-aminopyridine on neuromuscular transmission in disease states.
    Kim YI; Goldner MM; Sanders DB
    Muscle Nerve; 1980; 3(2):112-9. PubMed ID: 6245355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous transmitter release in experimental neuromuscular disorders of the rat.
    Thesleff SW
    Muscle Nerve; 1982; 5(9S):S12-6. PubMed ID: 6302487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium channel blockers and impulse propagation in murine motor endplate disease.
    Bournaud R; Mallart A
    Muscle Nerve; 1987 Jan; 10(1):1-5. PubMed ID: 2436044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dedifferentiation and remodeling of motor endplates following experimental localized lesions of muscle fibers].
    Couteaux R; Mira JC
    C R Acad Sci III; 1984; 299(9):389-96. PubMed ID: 6439396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the venom of the yellow Iranian scorpion Odontobuthus doriae on skeletal muscle preparations in vitro.
    Jalali A; Vatanpour H; Hosseininasab Z; Rowan EG; Harvey AL
    Toxicon; 2007 Dec; 50(8):1019-26. PubMed ID: 17976675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative electrophysiological study of motor end-plate diseased skeletal muscle in the mouse.
    Weinstein SP
    J Physiol; 1980 Oct; 307():453-64. PubMed ID: 7205674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular transmission in the murine mutants "motor end-plate disease" and "jolting".
    Harris JB; Pollard SL
    J Neurol Sci; 1986 Dec; 76(2-3):239-53. PubMed ID: 3025377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoglycosides and 3,4-diaminopyridine on neuromuscular block caused by botulinum type A toxin.
    Molgó J; Lemeignan M; Thesleff S
    Muscle Nerve; 1987 Jun; 10(5):464-70. PubMed ID: 3497343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in transmitter release from motor nerve terminals induced by some pyridine derivatives.
    Montoya GA; Molgó J; Lemeignan M; Lechat P
    Acta Physiol Pharmacol Latinoam; 1984; 34(4):409-18. PubMed ID: 6242265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facilitatory effects of 4-aminopyridine on normal neuromuscular transmission.
    Kim YI; Goldner MM; Sanders DB
    Muscle Nerve; 1980; 3(2):105-11. PubMed ID: 6245354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive transfer of the Lambert-Eaton myasthenic syndrome: neuromuscular transmission in mice injected with plasma.
    Kim YI
    Muscle Nerve; 1985 Feb; 8(2):162-72. PubMed ID: 2997605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle activity pattern regulates postnatal development of acetylcholinesterase molecular forms in normal mice and mice with motor endplate disease.
    Yeakley JM; Janavs JL; Reiness CG
    J Neurosci; 1987 Dec; 7(12):4084-94. PubMed ID: 3694264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation.
    Ribchester RR; Thomson D; Wood NI; Hinks T; Gillingwater TH; Wishart TM; Court FA; Morton AJ
    Eur J Neurosci; 2004 Dec; 20(11):3092-114. PubMed ID: 15579164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction.
    Thomsen RH; Wilson DF
    J Pharmacol Exp Ther; 1983 Oct; 227(1):260-5. PubMed ID: 6137556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced neuromuscular quantal content with normal synaptic release time course and depression in canine motor neuron disease.
    Rich MM; Wang X; Cope TC; Pinter MJ
    J Neurophysiol; 2002 Dec; 88(6):3305-14. PubMed ID: 12466448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miniature end-plate potential frequency in mouse dystrophic muscle [proceedings].
    Shalton PM; Wareham AC
    J Physiol; 1979 May; 290(2):24P-25P. PubMed ID: 469757
    [No Abstract]   [Full Text] [Related]  

  • 18. The motor unit in schizophrenic patients and their families.
    Peters JG
    Biol Psychiatry; 1978 Dec; 13(6):763-7. PubMed ID: 737264
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced endplate currents underlie motor unit dysfunction in canine motor neuron disease.
    Rich MM; Waldeck RF; Cork LC; Balice-Gordon RJ; Fyffe RE; Wang X; Cope TC; Pinter MJ
    J Neurophysiol; 2002 Dec; 88(6):3293-304. PubMed ID: 12466447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional motor unit failure precedes neuromuscular degeneration in canine motor neuron disease.
    Balice-Gordon RJ; Smith DB; Goldman J; Cork LC; Shirley A; Cope TC; Pinter MJ
    Ann Neurol; 2000 May; 47(5):596-605. PubMed ID: 10805330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.